| Autor: |
Andres Giglio Jimenez, Rodrigo Naser Abarzua, José Del Campo Peirano, Patricio Astudillo Paredes, Francisca García Hoffmann, Isabel Hoffmann Weinberg |
| Jazyk: |
English<br />Spanish; Castilian<br />Portuguese |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Respirar, Vol 15, Iss 4, Pp 227-233 (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2953-3414 |
| DOI: |
10.55720/respirar.15.4.2 |
| Popis: |
Introduction: The risk of pulmonary thromboembolism (PTE) in hospitalized patients is well known, but SARS-COV-2 (COVID-19) pandemic has increased its incidence, with varying evidence describing a prevalence of PTE of 3-8%. Methodology: Description of non-concurrent longitudinal cohort of hospitalized patients for SARS-COV2 infection with PTE in a tertiary complexity hospital. Clinical and epidemiological features were analyzed. Results: 151 patients were recruited with PTE and COVID-19 diagnosis, 3.4% of all hospitalized COVID patients. The median age was 67 years, 63% male patients, median length-of-stay (LOS) 20 days, and median time between COVID-19 to PTE diagnosis 13 days. Mortality at 30 days was PTE 17%, in-hospital mortality 23.1%. Mean PESI 107, Mean PESI of the deceased 116. Invasive mechanical ventilation prevalence was 31%. Discussion: 3.4% incidence of PTE in the cohort is in the lower incidence described in other centers, considering that there was no systematic search strategy for PTE. The increased risk of in-hospital mortality and overall mortality is an alert on the possible clinical impact and may indicate the need for closer surveillance in this population. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
